• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Merck

Merck

Merck & Co Inc MRK 3 Star

Last Price$59.28Day Change (%)-0.22%
Open Price$59.40Day Change ($)-0.13
Day Range59.25–59.9852-Week Range44.62–61.33

As of Tue 09/30/2014 04:02 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014

    Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014

  2. Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal

    Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal

  3. Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

    Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

  4. UPDATE: The ominous volatility burst and a trend to consider when picking those shorts

    UPDATE: The ominous volatility burst and a trend to consider when picking those shorts

  5. UPDATE: The ominous volatility burst and a trend to consider when picking those shorts

    UPDATE: The ominous volatility burst and a trend to consider when picking those shorts

  6. The ominous volatility burst and a trend to consider when picking those shorts

    The ominous volatility burst and a trend to consider when picking those shorts

  7. Nimbus Discovery Appoints Donald Nicholson, Ph.D. as Chief Executive Officer

    Nimbus Discovery Appoints Donald Nicholson, Ph.D. as Chief Executive Officer

  8. Inovio Pharmaceuticals Appoints Vice President of Commercial Development

    Inovio Pharmaceuticals Appoints Vice President of Commercial Development

  9. ADC Therapeutics Expands Team

    ADC Therapeutics Expands Team

  10. to-BBB Completes Management Team and Announces Company Name Change to BBB Therapeutics

    to-BBB Completes Management Team and Announces Company Name Change to BBB Therapeutics

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.